Skip to main content


Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort

Fig. 3

Subgroup analysis of RAT based on the baseline sUA level and renal function. The RAT in the Feb group, the Ben group, and subgroups after ULT for 12 weeks. The detail date was in the text. *P < 0.05 and **P < 0.01 vs. RAT of the alternative subgroup within the Feb or Ben group; #P < 0.05 and ##P < 0.01 vs. overall RAT of the Feb or Ben group

Back to article page